Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

R Pofi, G Caratti, DW Ray, JW Tomlinson - Endocrine Reviews, 2023 - academic.oup.com
It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

JS Smolen, R Landewé, FC Breedveld… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

[HTML][HTML] Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper

RF Spiera, S Unizony, KJ Warrington… - … England Journal of …, 2023 - Mass Medical Soc
Background More than half of patients with polymyalgia rheumatica have a relapse during
tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 …

[HTML][HTML] European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

L Gossec, JS Smolen, S Ramiro, M De Wit… - Annals of the …, 2016 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism
recommendations for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new …

Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease

DJ Gracie, EA Guthrie, PJ Hamlin, AC Ford - Gastroenterology, 2018 - Elsevier
Background & Aims Inflammatory bowel diseases (IBD) are associated with mood disorders,
such as anxiety or depression, but it is not clear whether one contributes to development of …

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

H Abu-Sbeih, FS Ali, D Alsaadi, J Jennings… - … for immunotherapy of …, 2018 - Springer
Background Immune-mediated diarrhea and colitis (IMDC) can limit immune checkpoint
inhibitors (ICIs) treatment, which is efficacious for advanced malignancies. Steroids and …

[HTML][HTML] European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

L Gossec, JS Smolen, C Gaujoux-Viala… - Annals of the …, 2012 - ard.bmj.com
Background Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual
treatment guidance focused on the musculoskeletal manifestations of PsA would be …

Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial

MF Bakker, JWG Jacobs, PMJ Welsing… - Annals of internal …, 2012 - acpjournals.org
Background: Treatment strategies for tight control of early rheumatoid arthritis (RA) are
highly effective but can be improved. Objective: To investigate whether adding prednisone …

Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years

L Fardet, I Petersen, I Nazareth - Rheumatology, 2011 - academic.oup.com
Objective. To assess trends in long-term (ie≥ 3 months) oral glucocorticoid (GC)
prescriptions over the past 20 years. Methods. Data of UK adult patients registered between …

Biomedical applications of polysaccharide nanoparticles for chronic inflammatory disorders: Focus on rheumatoid arthritis, diabetes and organ fibrosis

P Allawadhi, V Singh, K Govindaraj, I Khurana… - Carbohydrate …, 2022 - Elsevier
Polysaccharides are biopolymers distinguished by their complex secondary structures
executing various roles in microorganisms, plants, and animals. They are made up of long …